[OncoHost in NoCamels] 3 researchers developing innovative strategies in cancer therapy
Read more...
Read MoreFeb 3, 2022 | News Center
Read more...
Read MoreJan 24, 2022 | News Center
Needle-free blood tests, cosmic lightning, super-vegetables, and nano-ghosts are just a few of the innovative experiments Eytan Stibbe will test during his February mission to the International Space Station. Read...
Read MoreJan 12, 2022 | News Center, Newsticker
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced results from its ongoing multicenter clinical trial, PROPHETIC. These interim results confirm that through proteomic analysis of just one blood test before treatment, OncoHost’s AI platform, PROphet®, can predict response to cancer treatment for non-small cell lung cancer (NSCLC) patients with remarkably high accuracy at three months, six months and one year. Read...
Read MoreDec 17, 2021 | News Center
Graduates and professors of Israeli institute the Technion have made large contributions in the field of cancer research and treatment.Technion professor Yuval Shaked, together with startup OncoHost, is responsible for the creation of a blood test that will help doctors to provide personalized treatment plans to cancer patients, and plans for clinical trials in the UK in collaboration with the country’s National Healthcare System are in the works. Read...
Read MoreDec 13, 2021 | News Center
OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced a research collaboration with Lung Biobank Heidelberg, a member of BioMaterialBank Heidelberg (BMBH) and the German Center for Lung Research (DZL). Read...
Read More